§ BIOTECHNOLOGY
USD · BiotechnologyTRDA
ENTRADA THERAPEUTICS INC
USDSector · Biotechnology
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
84 increased/new, 31 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | 5.1M | 0.4% | ±0% |
| 5AM Venture Management, LLC | 4.1M | 14.2% | ±0% |
| BlackRock, Inc. | 2.4M | 0.0% | +10% |
| TCG Crossover Management, LLC | 2.3M | 0.8% | +10% |
| Merck & Co., Inc. | 1.7M | 6.3% | ±0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.3M | n/a | n/a |
◇ AC INTELLIGENCE
Top institutional owners for TRDA as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER25.0% · 0 holders
OTHER56.8% · 73 holders
PASSIVE / INDEX8.7% · 7 holders
DEALER / BANK4.2% · 18 holders
QUALITY / COMPOUNDER2.0% · 10 holders
TACTICAL / MACRO1.9% · 2 holders
SYSTEMATIC / QUANT0.9% · 4 holders
INCOME / DEFENSIVE0.3% · 5 holders
ACTIVIST0.2% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for TRDA in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention TRDA yet.